Organization

ACERE DRUGS INC

According to 2025 Medicare claims, ACERE DRUGS INC (NPI: 1770598385) practices mass immunization roster billers in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Hudson, NJ. This provider's primary affiliated billing organization is ACERE DRUGS INC (NPI: 1770598385) and primary practice location at 07087-3523.

The organization's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 30 traditional Medicare patients, billed 75 HCPCS/CPT codes, and received $5,555 in Medicare payments. The top billing code was 90662 (Influenza vaccine split virus, preservative free). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $6,312 and ending at $5,555. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	118	240	$6,312
2016	93	200	$6,397
2017	45	102	$3,860
2018	46	110	$4,495
2019	57	162	$8,560
2020	41	114	$5,049
2021	308	446	$18,550
2022	132	259	$10,804
2023	40	112	$8,590
2024	30	75	$5,555

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

No connected Part D records

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90662	Influenza vaccine split virus, preservative free	22	22	$82
G0008	Administration of influenza virus vaccine	24	24	$35

Top 5 Part D drugs in 2024

By total drug costs.

No connected Part D drug-level records for 2024.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for ACERE DRUGS INC?

Tedicare shows public-source Medicare data for ACERE DRUGS INC (NPI 1770598385), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does ACERE DRUGS INC have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to ACERE DRUGS INC?

ACERE DRUGS INC is linked to ACERE DRUGS INC (billing NPI 1770598385) in the available physician profile data.

Does ACERE DRUGS INC have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.